MetaCap

New Germany Fund (GF) vs abrdn Life Sciences Investors (HQL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

abrdn Life Sciences Investors offers the higher dividend yield (10.88% vs 2.71%).

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

GF versus HQL key metrics
MetricGFHQL
Share price$10.34$17.56
Market cap$168.54M—
1-day change-0.72%0.00%
YTD return—+4.65%
1-year return—+11.21%
5-year return—-15.00%
P/E ratio (TTM)—2.64
EPS (TTM)$-0.47$6.64
Dividend yield2.71%10.88%
Annual dividend$0.28$1.91
52-week high$12.49$22.67
52-week low$9.98$15.66
Distance from 52-week high-17.25%-22.54%
Average volume24.73K148.17K
Shares outstanding16.31M—
SectorFinancial ServicesFinancial Services
IndustryAsset ManagementAsset Management

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • abrdn Life Sciences Investors offers a meaningfully higher dividend yield (10.88% vs 2.71%).

About New Germany Fund

GF stock →

The New Germany Fund Inc. is a closed ended equity mutual fund launched by Deutsche Investment Management Americas Inc.

Financial Services · Asset Management

About abrdn Life Sciences Investors

HQL stock →

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.

Financial Services · Asset Management

GF vs HQL FAQ

Which pays a higher dividend, New Germany Fund or abrdn Life Sciences Investors?

abrdn Life Sciences Investors has the higher yield at 10.88%, compared with 2.71% for New Germany Fund.

Are New Germany Fund and abrdn Life Sciences Investors in the same industry?

Yes. Both are classified in the Asset Management industry within the Financial Services sector.

More comparisons